| Primary |
| Lung Adenocarcinoma |
100.0% |
|
| Hepatic Function Abnormal |
100.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
44.7% |
| Product Used For Unknown Indication |
13.0% |
| Foetal Exposure During Pregnancy |
7.2% |
| Acute Leukaemia |
3.7% |
| Depression |
3.2% |
| Asthma |
2.4% |
| Hodgkin's Disease |
2.4% |
| Nephroblastoma |
2.4% |
| Cytomegalovirus Infection |
2.1% |
| Hypertension |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Urinary Tract Infection |
2.1% |
| Crohn's Disease |
1.9% |
| Hiv Infection |
1.9% |
| Nasopharyngitis |
1.6% |
| Non-hodgkin's Lymphoma |
1.6% |
| Routine Health Maintenance |
1.6% |
| Bipolar Disorder |
1.3% |
| Drug Withdrawal Maintenance Therapy |
1.3% |
| Hypertonia |
1.3% |
|
| Foetal Exposure During Pregnancy |
19.8% |
| Vomiting |
7.4% |
| Exposure During Pregnancy |
6.2% |
| Overdose |
6.2% |
| Pneumonitis |
6.2% |
| Premature Baby |
6.2% |
| Respiratory Arrest |
6.2% |
| Suicide Attempt |
6.2% |
| Completed Suicide |
3.7% |
| Sepsis |
3.7% |
| Somnolence |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Tremor |
3.7% |
| Agranulocytosis |
2.5% |
| Constipation |
2.5% |
| Dermatitis Bullous |
2.5% |
| Generalised Oedema |
2.5% |
| Hospitalisation |
2.5% |
| Hypersensitivity |
2.5% |
| Inappropriate Schedule Of Drug Administration |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
41.8% |
| Product Used For Unknown Indication |
7.3% |
| Hypertension |
5.5% |
| Obesity |
5.2% |
| Hepatitis C |
4.5% |
| Rheumatoid Arthritis |
3.8% |
| Acne |
3.3% |
| Asthma |
3.3% |
| Non-small Cell Lung Cancer |
3.2% |
| Prophylaxis |
2.9% |
| Depression |
2.8% |
| Breast Cancer |
2.6% |
| Colon Cancer |
2.4% |
| Pain |
2.0% |
| Contraception |
1.8% |
| Hiv Infection |
1.8% |
| Neck Pain |
1.5% |
| Blood Pressure |
1.4% |
| Osteoporosis |
1.4% |
| Diabetes Mellitus |
1.3% |
|
| Vomiting |
14.2% |
| Stress |
8.4% |
| Pregnancy |
7.5% |
| Weight Decreased |
7.1% |
| Retinal Detachment |
6.7% |
| Thrombosis |
6.3% |
| Death |
5.4% |
| Pneumonia |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Type 1 Diabetes Mellitus |
4.2% |
| Myocardial Infarction |
3.8% |
| Tumour Marker Increased |
3.8% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Angina Pectoris |
2.9% |
| Delirium |
2.9% |
| Drug Ineffective |
2.9% |
| Stevens-johnson Syndrome |
2.9% |
| Hypophagia |
2.5% |
| Mucosal Inflammation |
2.5% |
| Syncope |
2.5% |
|
| Interacting |
| Gastrooesophageal Reflux Disease |
40.0% |
| Bipolar Disorder |
20.0% |
| Grand Mal Convulsion |
20.0% |
| Thyroid Disorder |
20.0% |
|
| Drug Interaction |
50.0% |
| Weight Decreased |
50.0% |
|
